Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 4
2006 6
2007 3
2008 2
2009 2
2010 2
2011 3
2012 5
2013 14
2014 12
2015 14
2016 11
2017 11
2018 12
2019 8
2020 13
2021 14
2022 9
2023 6
2024 17
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Results by year

Filters applied: . Clear all
Page 1
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer.
Cillo AR, Kürten CHL, Tabib T, Qi Z, Onkar S, Wang T, Liu A, Duvvuri U, Kim S, Soose RJ, Oesterreich S, Chen W, Lafyatis R, Bruno TC, Ferris RL, Vignali DAA. Cillo AR, et al. Among authors: kim s. Immunity. 2020 Jan 14;52(1):183-199.e9. doi: 10.1016/j.immuni.2019.11.014. Epub 2020 Jan 7. Immunity. 2020. PMID: 31924475 Free PMC article.
Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing.
Kürten CHL, Kulkarni A, Cillo AR, Santos PM, Roble AK, Onkar S, Reeder C, Lang S, Chen X, Duvvuri U, Kim S, Liu A, Tabib T, Lafyatis R, Feng J, Gao SJ, Bruno TC, Vignali DAA, Lu X, Bao R, Vujanovic L, Ferris RL. Kürten CHL, et al. Among authors: kim s. Nat Commun. 2021 Dec 17;12(1):7338. doi: 10.1038/s41467-021-27619-4. Nat Commun. 2021. PMID: 34921143 Free PMC article.
B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma.
Ruffin AT, Cillo AR, Tabib T, Liu A, Onkar S, Kunning SR, Lampenfeld C, Atiya HI, Abecassis I, Kürten CHL, Qi Z, Soose R, Duvvuri U, Kim S, Oesterrich S, Lafyatis R, Coffman LG, Ferris RL, Vignali DAA, Bruno TC. Ruffin AT, et al. Among authors: kim s. Nat Commun. 2021 Jun 7;12(1):3349. doi: 10.1038/s41467-021-23355-x. Nat Commun. 2021. PMID: 34099645 Free PMC article.
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial.
Davar D, Morrison RM, Dzutsev AK, Karunamurthy A, Chauvin JM, Amatore F, Deutsch JS, Das Neves RX, Rodrigues RR, McCulloch JA, Wang H, Hartman DJ, Badger JH, Fernandes MR, Bai Y, Sun J, Cole AM, Aggarwal P, Fang JR, Deitrick C, Bao R, Duvvuri U, Sridharan SS, Kim SW, A Choudry H, Holtzman MP, Pingpank JF, O'Toole JP, DeBlasio R, Jin Y, Ding Q, Gao W, Groetsch C, Pagliano O, Rose A, Urban C, Singh J, Divarkar P, Mauro D, Bobilev D, Wooldridge J, Krieg AM, Fury MG, Whiteaker JR, Zhao L, Paulovich AG, Najjar YG, Luke JJ, Kirkwood JM, Taube JM, Park HJ, Trinchieri G, Zarour HM. Davar D, et al. Among authors: kim sw. Cancer Cell. 2024 Nov 11;42(11):1898-1918.e12. doi: 10.1016/j.ccell.2024.10.007. Epub 2024 Oct 31. Cancer Cell. 2024. PMID: 39486411 Free article. Clinical Trial.
Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies.
Li H, Zandberg DP, Kulkarni A, Chiosea SI, Santos PM, Isett BR, Joy M, Sica GL, Contrera KJ, Tatsuoka CM, Brand M, Duvvuri U, Kim S, Kubik M, Sridharan S, Tu F, Chen J, Bruno TC, Vignali DAA, Cillo AR, Bao R, Wang JH, Vujanovic L, Ferris RL. Li H, et al. Among authors: kim s. Cancer Cell. 2025 Apr 14;43(4):757-775.e8. doi: 10.1016/j.ccell.2025.02.026. Epub 2025 Mar 13. Cancer Cell. 2025. PMID: 40086437 Free article. Clinical Trial.
Robotic-assisted oropharyngeal reconstruction.
Duvvuri U, Bonawitz SC, Kim S. Duvvuri U, et al. Among authors: kim s. J Robot Surg. 2013 Mar;7(1):9-14. doi: 10.1007/s11701-011-0326-z. Epub 2011 Nov 30. J Robot Surg. 2013. PMID: 27000886
Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer.
Chuckran CA, Cillo AR, Moskovitz J, Overacre-Delgoffe A, Somasundaram AS, Shan F, Magnon GC, Kunning SR, Abecassis I, Zureikat AH, Luketich J, Pennathur A, Sembrat J, Rojas M, Merrick DT, Taylor SE, Orr B, Modugno F, Buckanovich R, Schoen RE, Kim S, Duvvuri U, Zeh H, Edwards R, Kirkwood JM, Coffman L, Ferris RL, Bruno TC, Vignali DAA. Chuckran CA, et al. Among authors: kim s. Sci Transl Med. 2021 Dec 8;13(623):eabf8495. doi: 10.1126/scitranslmed.abf8495. Epub 2021 Dec 8. Sci Transl Med. 2021. PMID: 34878821 Free PMC article.
CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: A Review.
Contrera KJ, Spector ME, Pantanowitz L, Abukhiran IM, Vujanovic L, Whiteside TL, Mowery YM, Zandberg DP, Sriharan SS, Kim S, Wilke C, Skinner HD, Zevallos JP, Ferris RL. Contrera KJ, et al. Among authors: kim s. JCO Precis Oncol. 2024 Oct;8:e2400183. doi: 10.1200/PO.24.00183. Epub 2024 Nov 20. JCO Precis Oncol. 2024. PMID: 39565979 Review.
154 results